Skip to main content

Advertisement

Table 2 Participants’ characteristics and values for selected variables before the first allocation

From: Risk of hyperkalemia in patients with moderate chronic kidney disease initiating angiotensin converting enzyme inhibitors or angiotensin receptor blockers: a randomized study

  Olmesartan Enalapril P-value
(n = 17) (n = 13)
Age, years 60.2 (12.9) 59.9 (11.6) NS
Female, n (%) 8 (47.1) 2 (15.4) <0.0001
BMI, kg/m2 27.7 (6.2) 27.41 (4.1) NS
Systolic blood pressure, mm Hg 134.8 (4.2) 140.1 (4.2) NS
Diastolic blood pressure, mm Hg 78.7 (1.7) 76.2 (1.8) NS
Dyslipidaemia, n (%) 6 (35.3) 5 (38.5) NS
Serum creatinine, mg/dl 1.65 (0.07) 1.60 (0.06) NS
Glomerular filtration rate, ml/min/1.73 m2 42.24 (2.0) 46.2 (1.9) NS
Plasma renin activity, ng/ml/h 1.13 (1.12) 1.30 (1.46) NS
Plasma aldosterone, ng/dl 30.6 (4.0) 27.1 (5.5) NS
Diabetic patients, n (%) 1 (5,8) 2(15) NS
  1. BMI: Body mass index, NS: no significant.
  2. Values are expressed as mean ± SE of the mean.